Navigation Links
Amira Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
Date:9/3/2009

SAN DIEGO, Sept. 3 /PRNewswire/ -- Amira Pharmaceuticals, Inc., a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease, announced today that Robert Baltera, Chief Executive Officer, will present a company overview at the Thomas Weisel Partners Healthcare Conference. The presentation is scheduled for 8:35 a.m. EDT on Wednesday, September 9, 2009, at The Four Seasons Hotel in Boston.

About Amira

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Our discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.

Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. Its scientific founders have successfully worked together for more than a decade and were pivotal in the discovery of a number of inflammatory drugs, including Singulair(R). The drug hunters at Amira are now actively leveraging their history of success to create high-value compounds for the future. For more information, visit www.amirapharm.com.


'/>"/>
SOURCE Amira Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
2. Amira Pharmaceuticals Appoints First Vice President of Development
3. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
4. Dr. Dennis Fenton and Dr. Steve Kaldor Join Amira Board of Directors
5. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
6. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
7. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
8. Amira Pharmaceuticals to Present Preclinical Data from LPA1 Receptor Antagonist Program at FASEB Summer Research Conference
9. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Dennis Thompson HealthDay Reporter ... people with depression are more likely to develop dementia, but ... the relationship between the two. Specifically, they haven,t been ... works -- does depression help bring on dementia, or does ... published online July 30 in the journal Neurology ...
(Date:7/30/2014)... Ticket Down is a reputable source for ... MI on Saturday, August 2nd. Two of the most ... competing on American soil on Aug. 2 when Manchester United and ... The home of the University of Michigan is also known as ... all of American sports and has also hosted numerous other monumental ...
(Date:7/30/2014)... VA (PRWEB) July 30, 2014 ... be featured in an upcoming episode of Innovations ... via Discovery Channel. Dates and show times TBA. ... on Good Neighbor Community Services’ vision to redefine ... providing individualized and dynamic services. Through passion, innovation, ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July ... their preschooler shed excess pounds may want to team up ... joined them in a supervised behavioral modification program gained less ... child-only program (an average difference of about four pounds over ... pounds over two years, according to the study. "In ...
(Date:7/30/2014)... Volunteers from the Church of Scientology of Denmark ... with massive distribution of Truth About Drugs ... on Strøget, the famous Copenhagen walking street. Popular ... its ambiance, some quarter of a million people stroll ... , These activities are part of a coordinating effort ...
Breaking Medicine News(10 mins):Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 2Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 3Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 4Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 4
... 90% adhered to fluid restriction, weigh-ins when aided by ... -- Intensive support from a heart failure nurse and ... patients will comply with crucial non-medical interventions, such as ... study by Dutch researchers. , "We examined the ...
... meds reduced risk by as much as 60%, researchers ... over-the-counter pain medicines called non-steroidal anti-inflammatory drugs (NSAIDs) may ... study by researchers at the UCLA School of Public ... men and women (half with Parkinson,s disease) who were ...
... liver transplantation who also suffer from other medical ... These comorbid problems, which include coronary disease, diabetes, ... and renal insufficiency, have been incorporated into a ... survival. These findings are published in the November ...
... ANGELES, Nov. 5 Tri-Isthmus Group, Inc.,("TIGroup"), (OTC ... the healthcare industry, announced the acquisition of a ... in Oklahoma City,RHA owns and operates three critical ... TIGroup,s Chairman and CEO, David Hirschhorn said, ...
... Video Captures Support for Contributions to the Environment and ... ... a new online video and podcast,released today, 14 globally recognized and ... food,crops over the last decade -- including their proven safety, benefits ...
... Rehabilitation on Heart Disease Patients with,Depression To ... Scientific,Sessions in Orlando, FLUSHING, N.Y., Nov. 5 ... New York Hospital Queens Heart and Vascular,Center demonstrates ... positive impact on depression in patients with coronary ...
Cached Medicine News:Health News:Nurse-Led Intervention Boosts Cardiac Rehab: Study 2Health News:NSAIDs Protect Against Parkinson's Disease 2Health News:Predicting survival after liver transplantation 2Health News:TIGroup Acquires Controlling Interest in Healthcare Services Provider 2Health News:TIGroup Acquires Controlling Interest in Healthcare Services Provider 3Health News:Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 2Health News:Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 3Health News:Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 4Health News:New York Hospital Queens Cardiac Rehabilitation Team Presents Study at World's Leading Heart Disease Conference 2Health News:New York Hospital Queens Cardiac Rehabilitation Team Presents Study at World's Leading Heart Disease Conference 3
(Date:7/30/2014)... NEW YORK , July 30, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.html Executive ... services are delivered, leading to better outcomes, decreased ... The market for mHealth solutions is still in ...
(Date:7/30/2014)... 30, 2014  InnoPharma, Inc. today announced the first ... equivalent of Zyprexa® injection), in Canada.  Olanzapine is indicated ... in patients with schizophrenia or bipolar I mania. ... InnoPharma has entered into an agreement with Sandoz Canada ... make, use, sell, market and distribute Olanzapine Injection in ...
(Date:7/30/2014)... , July 30, 2014 Stryker brand ambassadors ... week at the 3M Championship Champions Tour event near ... in Blaine . Stryker is the official joint ... Starting Friday, August 1 st through Sunday, August ... Mobility Zone; an on-site joint health destination located in the Pioneer ...
Breaking Medicine Technology:mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... Accu-Temp Cauteries provide a broad ... cauterization in a wide variety ... use cautery is packaged sterile, ... to lock switch in the ...
... Accu-Temp Cauteries provide a broad ... in a wide variety of ophthalmic ... packaged sterile, complete with a safety ... "off " position when not in ...
... visual acuity system allows you access to ... II. The system includes 10 different optotypes, ... and animated characters. Random character sequencing eliminates ... letter, single line and multiple line selection ...
Medicine Products: